Press release
Chemotherapy-Induced Anemia Market Demand and Growth Opportunities Detailed Analysis Report 2024-2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Chemotherapy-Induced Anemia Market- (By Type of Anemia (Mild Anemia, Moderate Anemia, Severe Anemia, Life-Threatening Anemia), By Treatment Type (RBC Transfusion, Erythropoiesis-stimulating agents (ESAs), Iron Supplementation), By Drug Type (Epogen Injection, Procrit Injection, Androxy Oral, Aranesp Injection, Epoetin Alfa Injection, and Others), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Chemotherapy-Induced Anemia Market is valued at US$ 2.4 Bn in 2023, and it is expected to reach US$ 3.9 Bn by 2031, with a CAGR of 6.5% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2511
In chemotherapy-induced anemia, a patient has a decrease in hemoglobin while receiving chemotherapy. This disorder arises as a result of the fact that chemotherapy medications frequently target cells that divide quickly. The worldwide market for chemotherapy-induced anemia is anticipated to experience an increase due, in part, to the high incidence of both cancer and anemia among the elderly. The invasion of bone marrow and the development of systemic inflammatory illness are driving up the demand for chemotherapy-induced anemia. Innovation and progress, technological developments, government incentives, and enhancements in pipeline items are also anticipated to be major drivers of market expansion over the projected time.
The possibility of beneficial reimbursement policies is anticipated to create lucrative prospects for market growth in the coming years. However, the industry is expected to be hindered by regulatory hurdles related to approving and utilising chemotherapy-induced anemia treatment. Also, the market is expected to slow down throughout the projected period due to specific manufacturing and pharmacological challenges associated with this chemotherapy-induced anemia therapy development. As a result of increased knowledge of chemotherapy-induced anemia and advancements in diagnostic techniques, chemotherapy patients with anemia can be better identified and treated, driving the market forward. These factors are expected to drive the growth of the chemotherapy-induced anemia market during the projected timeframe.
List of Prominent Players in the Chemotherapy-Induced Anemia Market:
• Astellas Pharma Inc.
• Blausen Medical
• Dr. Reddy's Laboratories Ltd.
• Elsevier Inc.
• F. Hoffmann-La Roche Ltd
• FibroGen, Inc.
• GlaxoSmithKline PLC
• Healio
• Johnson & Johnson
• Karger AG
• Novartis AG
• Pfizer Inc.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02
Market Dynamics:
Drivers-:
The increasing rate of cancer cases worldwide is a key factor propelling the chemotherapy-induced anemia market. As the number of cancer patients undergoing chemotherapy rises, so does the number of people experiencing anemia as a typical side effect. There is a growing need for better anemia management due to the fact that chemotherapy has become harsh with the advancements in the field. In addition, there is a growing demand for supportive therapy due to increased awareness and better diagnostic methods that allow for better detection of chemotherapy-induced anemia. The market is being driven by the increasing size of the senior population, who are at a higher risk of developing cancer.
Challenges:
A major obstacle to the chemotherapy-induced anemia market is the regulatory climate, which requires lengthy clinical trials and strict permissions, which slows down the launch of novel medications. In addition, the market is also hindered by the expansion due to concerns over the safety profile of particular medicines. In addition, the availability of less expensive and more accessible alternatives to blood transfusions and other new anemia treatments can minimize the need for chemotherapy-induced anemia treatments.
Regional Trends:
The North American chemotherapy-induced anemia market is anticipated to register a major market share in revenue. It is projected to grow at a high CAGR in the near future because of the improved healthcare system and the proliferation of chemotherapeutic drugs. Also, the aging population is expected to experience lucrative growth in the next years as a result of the rising rates of cancer and anemia. Besides, Europe had a substantial share in the market because of the rapid urbanization, enhanced healthcare facilities, and abundant discretionary income, escalating rates of cancer as a result of unhealthy lifestyle choices, significant population suffering from anemia, and medical travel is on the rise, as a result of the dramatic rise in chemotherapy-induced anemia market in this region.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2511
Recent Developments:
• In May 2024, Xyphos Biosciences, Inc., a wholly-owned subsidiary of Astellas, and Poseida Therapeutics, Inc., a publicly traded company, announced that they have formed a research collaboration and license agreement to create new convertible car programs. This will be achieved by combining the cutting-edge cell therapy platforms of both companies.
• ·In March 2024, Elsevier, a world leader in providing information solutions and products for science, technology, and medicine, is pleased to announce the launch of a new open-access journal, CMI Communications, in collaboration with ESCMID, the leading European society for clinical microbiology and infectious diseases.
Segmentation of Chemotherapy-Induced Anemia Market-
Chemotherapy-Induced Anemia Market-By Type of Anemia
• Mild Anemia
• Moderate Anemia
• Severe Anemia
• Life-Threatening Anemia
Chemotherapy-Induced Anemia Market-By Treatment Type
• RBC Transfusion
• Erythropoiesis-stimulating agents (ESAs)
• Iron Supplementation
Chemotherapy-Induced Anemia Market-By Drug Type
• Epogen Injection
• Procrit Injection
• Androxy Oral
• Aranesp Injection
• Epoetin Alfa Injection
• Others
Chemotherapy-Induced Anemia Market-By End-User
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others
Chemotherapy-Induced Anemia Market-By Region
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/2511
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
According to the latest research by InsightAce Analytic, the Global Chemotherapy-Induced Anemia Market is valued at US$ 2.4 Bn in 2023, and it is expected to reach US$ 3.9 Bn by 2031, with a CAGR of 6.5% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2511
In chemotherapy-induced anemia, a patient has a decrease in hemoglobin while receiving chemotherapy. This disorder arises as a result of the fact that chemotherapy medications frequently target cells that divide quickly. The worldwide market for chemotherapy-induced anemia is anticipated to experience an increase due, in part, to the high incidence of both cancer and anemia among the elderly. The invasion of bone marrow and the development of systemic inflammatory illness are driving up the demand for chemotherapy-induced anemia. Innovation and progress, technological developments, government incentives, and enhancements in pipeline items are also anticipated to be major drivers of market expansion over the projected time.
The possibility of beneficial reimbursement policies is anticipated to create lucrative prospects for market growth in the coming years. However, the industry is expected to be hindered by regulatory hurdles related to approving and utilising chemotherapy-induced anemia treatment. Also, the market is expected to slow down throughout the projected period due to specific manufacturing and pharmacological challenges associated with this chemotherapy-induced anemia therapy development. As a result of increased knowledge of chemotherapy-induced anemia and advancements in diagnostic techniques, chemotherapy patients with anemia can be better identified and treated, driving the market forward. These factors are expected to drive the growth of the chemotherapy-induced anemia market during the projected timeframe.
List of Prominent Players in the Chemotherapy-Induced Anemia Market:
• Astellas Pharma Inc.
• Blausen Medical
• Dr. Reddy's Laboratories Ltd.
• Elsevier Inc.
• F. Hoffmann-La Roche Ltd
• FibroGen, Inc.
• GlaxoSmithKline PLC
• Healio
• Johnson & Johnson
• Karger AG
• Novartis AG
• Pfizer Inc.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02
Market Dynamics:
Drivers-:
The increasing rate of cancer cases worldwide is a key factor propelling the chemotherapy-induced anemia market. As the number of cancer patients undergoing chemotherapy rises, so does the number of people experiencing anemia as a typical side effect. There is a growing need for better anemia management due to the fact that chemotherapy has become harsh with the advancements in the field. In addition, there is a growing demand for supportive therapy due to increased awareness and better diagnostic methods that allow for better detection of chemotherapy-induced anemia. The market is being driven by the increasing size of the senior population, who are at a higher risk of developing cancer.
Challenges:
A major obstacle to the chemotherapy-induced anemia market is the regulatory climate, which requires lengthy clinical trials and strict permissions, which slows down the launch of novel medications. In addition, the market is also hindered by the expansion due to concerns over the safety profile of particular medicines. In addition, the availability of less expensive and more accessible alternatives to blood transfusions and other new anemia treatments can minimize the need for chemotherapy-induced anemia treatments.
Regional Trends:
The North American chemotherapy-induced anemia market is anticipated to register a major market share in revenue. It is projected to grow at a high CAGR in the near future because of the improved healthcare system and the proliferation of chemotherapeutic drugs. Also, the aging population is expected to experience lucrative growth in the next years as a result of the rising rates of cancer and anemia. Besides, Europe had a substantial share in the market because of the rapid urbanization, enhanced healthcare facilities, and abundant discretionary income, escalating rates of cancer as a result of unhealthy lifestyle choices, significant population suffering from anemia, and medical travel is on the rise, as a result of the dramatic rise in chemotherapy-induced anemia market in this region.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2511
Recent Developments:
• In May 2024, Xyphos Biosciences, Inc., a wholly-owned subsidiary of Astellas, and Poseida Therapeutics, Inc., a publicly traded company, announced that they have formed a research collaboration and license agreement to create new convertible car programs. This will be achieved by combining the cutting-edge cell therapy platforms of both companies.
• ·In March 2024, Elsevier, a world leader in providing information solutions and products for science, technology, and medicine, is pleased to announce the launch of a new open-access journal, CMI Communications, in collaboration with ESCMID, the leading European society for clinical microbiology and infectious diseases.
Segmentation of Chemotherapy-Induced Anemia Market-
Chemotherapy-Induced Anemia Market-By Type of Anemia
• Mild Anemia
• Moderate Anemia
• Severe Anemia
• Life-Threatening Anemia
Chemotherapy-Induced Anemia Market-By Treatment Type
• RBC Transfusion
• Erythropoiesis-stimulating agents (ESAs)
• Iron Supplementation
Chemotherapy-Induced Anemia Market-By Drug Type
• Epogen Injection
• Procrit Injection
• Androxy Oral
• Aranesp Injection
• Epoetin Alfa Injection
• Others
Chemotherapy-Induced Anemia Market-By End-User
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others
Chemotherapy-Induced Anemia Market-By Region
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/2511
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
